Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Bioresponsive nanosensors in medical imaging.

Literature DB >> 19846442

Bioresponsive nanosensors in medical imaging.

Abstract

Superparamagnetic iron oxide nanoparticles have been established as sensitive probes for magnetic resonance imaging (MRI). While the majority of specific nanosensors are based on sterically stabilized iron oxide particles, the focus of this review is on the use of very small iron oxide particles (VSOPs) that are electrostatically stabilized by an anionic citrate acid shell. We used VSOPs to develop target-specific as well as protease-activatable nanosensors for molecular MRI.

Entities: Chemical

Mesh：

Substances：

Year: 2009 PMID： 19846442 PMCID： PMC2843987 DOI： 10.1098/rsif.2009.0336.focus

Source DB: PubMed Journal: J R Soc Interface ISSN： 1742-5662 Impact factor: 4.118

40 in total

Review 1. Looking and listening to light: the evolution of whole-body photonic imaging.

Authors: Vasilis Ntziachristos; Jorge Ripoll; Lihong V Wang; Ralph Weissleder
Journal: Nat Biotechnol Date: 2005-03 Impact factor: 54.908

Review 2. Recent advances in iron oxide nanocrystal technology for medical imaging.

Authors: Claire Corot; Philippe Robert; Jean-Marc Idée; Marc Port
Journal: Adv Drug Deliv Rev Date: 2006-09-30 Impact factor: 15.470

3. Stealth PEG-PHDCA niosomes: effects of chain length of PEG and particle size on niosomes surface properties, in vitro drug release, phagocytic uptake, in vivo pharmacokinetics and antitumor activity.

Authors: Bin Shi; Chao Fang; Yuanying Pei
Journal: J Pharm Sci Date: 2006-09 Impact factor: 3.534

Review 4. Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases.

Authors: Jialiang Hu; Philippe E Van den Steen; Qing-Xiang A Sang; Ghislain Opdenakker
Journal: Nat Rev Drug Discov Date: 2007-06 Impact factor: 84.694

Review 5. Use of protamine to rapidly reverse anticoagulant effect of unfractionated heparin in patients undergoing percutaneous coronary intervention.

Authors: Aarti A Patel; C Michael White; Craig I Coleman
Journal: Conn Med Date: 2007-02

6. In vivo imaging of apoptosis in patients with acute stroke: correlation with blood-brain barrier permeability.

Authors: Mordechai Lorberboym; Francis G Blankenberg; Menahem Sadeh; Yair Lampl
Journal: Brain Res Date: 2006-06-30 Impact factor: 3.252

7. Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle.

Authors: David E Sosnovik; Eyk A Schellenberger; Matthias Nahrendorf; Mikhail S Novikov; Takashi Matsui; George Dai; Fred Reynolds; Luanda Grazette; Anthony Rosenzweig; Ralph Weissleder; Lee Josephson
Journal: Magn Reson Med Date: 2005-09 Impact factor: 4.668

8. Biomimetic amplification of nanoparticle homing to tumors.

Authors: Dmitri Simberg; Tasmia Duza; Ji Ho Park; Markus Essler; Jan Pilch; Lianglin Zhang; Austin M Derfus; Meng Yang; Robert M Hoffman; Sangeeta Bhatia; Michael J Sailor; Erkki Ruoslahti
Journal: Proc Natl Acad Sci U S A Date: 2007-01-10 Impact factor: 11.205

Bioresponsive nanosensors in medical imaging.

Review 1. Looking and listening to light: the evolution of whole-body photonic imaging.

Review 2. Recent advances in iron oxide nanocrystal technology for medical imaging.

3. Stealth PEG-PHDCA niosomes: effects of chain length of PEG and particle size on niosomes surface properties, in vitro drug release, phagocytic uptake, in vivo pharmacokinetics and antitumor activity.

Review 4. Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases.

Review 5. Use of protamine to rapidly reverse anticoagulant effect of unfractionated heparin in patients undergoing percutaneous coronary intervention.

6. In vivo imaging of apoptosis in patients with acute stroke: correlation with blood-brain barrier permeability.

7. Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle.

8. Biomimetic amplification of nanoparticle homing to tumors.

9. Sequential 99mTc-hydrazinonicotinamide-annexin V imaging for predicting response to chemotherapy.

10. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes.

Review 1. Near-infrared fluorescent nanoprobes for cancer molecular imaging: status and challenges.

2. NanoBioInterface: a multidisciplinary challenge.

3. A molecular MRI probe to detect treatment of cardiac apoptosis in vivo.

Review 4. Recent Developments in Nanosensors for Imaging Applications in Biological Systems.

5. Magnetic nanoparticles for biomedical NMR-based diagnostics.

Review 6. Different Approaches to Develop Nanosensors for Diagnosis of Diseases.